US Edition
Positive results in implant trial to treat glaucoma, diabetic retinopathy
Summary by Insight
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Positive results in implant trial to treat glaucoma, diabetic retinopathy
Sixty patients were treated in both trials, with 33 participants enrolled in the glaucoma research. Image: Yakobchuk Olena/stock.adobe.com.Perfuse Therapeutics, Inc., a US biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, has announced positive results from two Phase 2 clinical trials of PER-001, a novel therapeutic designed to address two leading causes of global blindness: glaucoma and d…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
